Home / Inspections / 1246375

FDA Inspection 1246375 — Mercy Hospital Springfield - Transfusion Services

Mercy Hospital Springfield - Transfusion Services — FEI 1970683

The FDA completed an inspection of Mercy Hospital Springfield - Transfusion Services on July 10, 2024 in Springfield, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 10, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Springfield, MO (United States)

Facility

Other inspections at this facility

  • 1084864 (NAI Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 995151 (NAI Mon Dec 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 919959 (NAI Fri Mar 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 890936 (NAI Thu Aug 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 822841 (NAI Wed Mar 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources